(Reuters) - Switzerland's Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.
from Reuters: Health News http://ift.tt/2EL9X0J February 16, 2018 at 09:10AM
No comments:
Post a Comment